Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 17137557 | CONTROLLED AGGREGATION OF CELLS | December 2020 | July 2024 | Abandon | 42 | 2 | 0 | No | No |
| 17129058 | PROCESS FOR PRODUCING FUEL USING TWO FERMENTATIONS | December 2020 | August 2023 | Allow | 32 | 0 | 1 | No | No |
| 17128654 | CLEARING REAGENT FOR BIOLOGICAL MATERIAL, AND USE THEREOF | December 2020 | February 2025 | Abandon | 50 | 4 | 0 | Yes | No |
| 17128303 | METHOD FOR MAKING BIOLOGICAL MATERIAL TRANSPARENT AND USE THEREOF | December 2020 | February 2025 | Abandon | 50 | 4 | 0 | Yes | No |
| 17253118 | EVALUATION METHOD FOR GENOMIC ABNORMALITIES IN CELLS | December 2020 | May 2025 | Abandon | 53 | 1 | 1 | No | No |
| 17111147 | SOFT TISSUE REPAIR AND METHODS FOR PREPARING SAME | December 2020 | October 2023 | Allow | 35 | 1 | 1 | No | No |
| 17111390 | B-CELL CULTIVATION METHOD | December 2020 | November 2023 | Abandon | 35 | 1 | 0 | No | No |
| 17057678 | ANTIBACTERIAL PHAGE, THERAPEUTIC COMPOSITION, BACTERICIDAL AGENT, FOOD, BACTERIA IDENTIFICATION KIT, THERAPEUTIC COMPOSITION MANUFACTURING METHOD, BACTERIA ELIMINATION METHOD, BACTERIA IDENTIFICATION METHOD, AND ANIMAL THERAPEUTIC METHOD | November 2020 | March 2024 | Abandon | 40 | 1 | 0 | No | No |
| 17056527 | Suppression of Bone Cancer-induced Allodynia | November 2020 | January 2024 | Allow | 38 | 1 | 0 | No | No |
| 17099122 | METHODS AND COMPOSITIONS FOR PROMOTING SURVIVAL AND PROLIFERATION OF ENDOTHELIAL CELLS AND STIMULATING ANGIOGENSIS | November 2020 | October 2023 | Allow | 35 | 1 | 0 | Yes | No |
| 17097987 | TISSUE FRAGMENT | November 2020 | October 2023 | Abandon | 35 | 1 | 0 | No | No |
| 17091286 | DETERGENT COMPOSITION | November 2020 | January 2024 | Abandon | 38 | 1 | 1 | No | No |
| 17084929 | RECOMBINANT ORGANISMS AND METHODS FOR PRODUCING GLYCOMOLECULES WITH HIGH GLYCAN OCCUPANCY | October 2020 | June 2024 | Abandon | 43 | 0 | 1 | No | No |
| 17083531 | Compositions and methods for stable isotope labelling of biological compounds | October 2020 | March 2025 | Abandon | 53 | 3 | 0 | No | No |
| 17082166 | PHOTOTROPHIC PURIFICATION OF HYDROGEN SULFIDE CONTAINING STREAMS | October 2020 | June 2024 | Allow | 43 | 0 | 2 | Yes | No |
| 17081983 | APPARATUSES AND METHODS USING NANOSTRAWS TO DELIVER BIOLOGICALLY RELEVANT CARGO INTO NON-ADHERENT CELLS | October 2020 | January 2024 | Allow | 39 | 1 | 1 | No | No |
| 17075116 | SELECTIVE DELIVERY OF MATERIAL TO CELLS | October 2020 | July 2023 | Allow | 32 | 1 | 0 | No | No |
| 17042751 | Application of Lentiviral Vector EF1alpha Promoter for Optimising ABCD1 Gene Expression to Treat Adrenoleukodystrophy | September 2020 | April 2024 | Allow | 43 | 1 | 1 | No | No |
| 17031206 | BIOARTIFICIAL PANCREAS | September 2020 | October 2023 | Abandon | 37 | 0 | 1 | No | No |
| 17024684 | METHOD FOR PREPARING BONE GRAFT COMPOSITION AND BONE GRAFT COMPOSITION | September 2020 | December 2023 | Abandon | 39 | 1 | 1 | No | No |
| 17015813 | MICROTOME SECTIONABLE GEL SUPPORT STRUCTURE AND METHODS | September 2020 | June 2023 | Allow | 34 | 1 | 0 | No | No |
| 17013454 | SYSTEMS AND METHODS FOR SEEDING CELL CULTURES IN A MICROFLUIDIC DEVICE | September 2020 | May 2023 | Allow | 32 | 1 | 1 | Yes | No |
| 17004857 | COMPOSITIONS AND METHODS FOR PRODUCING CLOSTRIDIAL COLLAGENASES | August 2020 | September 2024 | Abandon | 48 | 3 | 0 | No | No |
| 17005118 | RUSALATIDE ACETATE COMPOSITIONS | August 2020 | December 2023 | Allow | 39 | 2 | 1 | Yes | No |
| 16989554 | METHODS OF GENERATING HUMAN INNER EAR SENSORY EPITHELIA AND SENSORY NEURONS | August 2020 | April 2024 | Allow | 45 | 3 | 0 | Yes | No |
| 16933253 | RAPID SPERM SEPARATION BASED ON SPERM MORPHOLOGY AND MOTILITY | July 2020 | July 2023 | Abandon | 36 | 1 | 0 | No | No |
| 16927068 | PHARMACEUTICAL PREPARATIONS OF HUMAN RPE CELLS AND USES THEREOF | July 2020 | February 2025 | Abandon | 55 | 4 | 0 | No | No |
| 16922493 | COMPOSITIONS AND METHODS FOR MAXIMIZING MALONYL-COA IN E. COLI | July 2020 | April 2024 | Abandon | 45 | 3 | 0 | Yes | No |
| 16909616 | ENHANCED DIFFERENTIATION OF MESENCHYMAL STEM CELLS | June 2020 | October 2024 | Allow | 52 | 5 | 0 | Yes | Yes |
| 16909806 | COMPOSITIONS AND METHODS FOR MULTIPLEXED QUANTITATIVE ANALYSIS OF CELL LINEAGES | June 2020 | April 2024 | Abandon | 46 | 0 | 1 | No | No |
| 16765196 | MICROBIAL HOST CELLS FOR PRODUCTION OF STEVIOL GLYCOSIDES | May 2020 | January 2023 | Abandon | 32 | 0 | 1 | No | No |
| 16878510 | METHOD FOR ASSESSMENT OF HEPATIC FUNCTION AND PORTAL BLOOD FLOW | May 2020 | January 2024 | Allow | 44 | 3 | 1 | Yes | No |
| 16856608 | DENTAL PRETREATMENT MATERIAL AND DENTAL TISSUE REGENERATION KIT | April 2020 | October 2022 | Abandon | 30 | 1 | 0 | No | No |
| 16853865 | Methods for Fluid Mixing Systems with Laterally Displaced Flexible Drive Lines | April 2020 | April 2024 | Allow | 48 | 2 | 1 | Yes | No |
| 16850919 | DRY MATRIX FOR EMBEDDING VIABLE ESCHERICHIA COLI, METHOD OF MAKING SAME AND USE THEREOF | April 2020 | March 2024 | Abandon | 47 | 4 | 0 | No | No |
| 16843951 | Systems and Methods For Isolating Microvessels From Adipose Tissue | April 2020 | October 2023 | Abandon | 42 | 2 | 1 | No | No |
| 16832446 | APPARATUS AND METHOD OF AIR-SUSPENDED BIOFABRICATION OF TISSUE-ENGINEERED ORGAN CONSTRUCTS AND CONGLOMERATES OF SPHEROIDS, CELLS AND OTHER BIOLOGICAL OBJECTS BY USING MAGNETIC FIELD | March 2020 | March 2023 | Abandon | 35 | 0 | 1 | No | No |
| 16651974 | Isothiocyanate containing Brassicaceae Products and Method of Preparation Thereof | March 2020 | September 2024 | Allow | 54 | 4 | 1 | Yes | No |
| 16825225 | HIGH POTENCY STABLE FORMULATIONS OF VAGINAL LACTOBACILLUS | March 2020 | April 2021 | Allow | 12 | 2 | 1 | Yes | No |
| 16781764 | PACKED-BED BIOREACTOR SYSTEMS AND METHODS OF USING THE SAME | February 2020 | October 2024 | Abandon | 56 | 4 | 1 | No | No |
| 16774211 | Method and System for Treatment of Microorganisms during Propagation, Conditioning, Fermentation, and Preservation Using LAE and Selected Additives | January 2020 | November 2024 | Abandon | 58 | 4 | 0 | No | Yes |
| 16625579 | ENGINEERED AND FULLY-FUNCTIONAL CUSTOMIZED GLYCOPROTEINS | December 2019 | October 2023 | Allow | 45 | 2 | 1 | Yes | No |
| 16717411 | DRY MATRIX FOR EMBEDDING VIABLE ESCHERICHIA COLI, METHOD OF MAKING SAME AND USE THEREOF | December 2019 | March 2024 | Abandon | 51 | 4 | 0 | No | No |
| 16715905 | COMPOSITIONS OF CITRULLINE | December 2019 | June 2023 | Abandon | 42 | 1 | 1 | No | No |
| 16621528 | CORNEAL ENDOTHELIAL CELL MARKER AND USE THEREOF | December 2019 | July 2023 | Allow | 43 | 2 | 0 | No | No |
| 16707804 | METHODS AND SYSTEMS FOR CONVERSION OF BIOMASS MATERIALS INTO BIOFUELS AND BIOCHEMICALS | December 2019 | January 2024 | Abandon | 49 | 4 | 0 | Yes | No |
| 16705344 | CELL SHEET CONSTRUCT FOR NEUROVASCULAR RECONSTRUCTION AND MANUFACTURE THEREOF | December 2019 | January 2023 | Allow | 38 | 2 | 1 | No | No |
| 16705314 | CELL SHEET CONSTRUCT FOR NEUROVASCULAR RECONSTRUCTION AND MANUFACTURE THEREOF | December 2019 | June 2022 | Allow | 31 | 1 | 0 | No | No |
| 16620395 | METHOD FOR REMOVING UNDIFFERENTIATED PLURIPOTENT STEM CELLS | December 2019 | February 2025 | Allow | 60 | 2 | 1 | Yes | No |
| 16703511 | Bacterial Growth on Non-Animal Derived Media | December 2019 | March 2025 | Abandon | 60 | 6 | 0 | Yes | No |
| 16700990 | CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE | December 2019 | October 2022 | Abandon | 34 | 0 | 1 | No | No |
| 16700189 | METHOD FOR TREATING INTESTINAL GLUTAMINE SYNTHETASE ACTIVITY DEFICIENCY | December 2019 | October 2022 | Abandon | 35 | 1 | 1 | No | No |
| 16701013 | CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE | December 2019 | November 2021 | Abandon | 24 | 2 | 1 | No | Yes |
| 16698403 | HUNTER SYNDROME THERAPEUTIC AGENT AND TREATMENT METHOD | November 2019 | August 2022 | Abandon | 32 | 3 | 0 | No | No |
| 16617998 | MATRIX OF RICE HUSK SILICA FOR IMMOBILIZING ENZYME AND USES THEREOF | November 2019 | February 2024 | Abandon | 51 | 3 | 1 | No | No |
| 16698666 | PROVIDENT METHOD OF CELLULASES ENZYMES PRODUCTION BY PENICILLIUM FUNICULOSUM MRJ-16 USING LOW COST MEDIA COMPONENTS | November 2019 | August 2021 | Allow | 20 | 1 | 0 | No | No |
| 16616627 | Nanocone Structure Composite Material for Capturing Cancer Cells, Preparation Method Therefor and Use Thereof | November 2019 | March 2024 | Abandon | 52 | 3 | 1 | No | No |
| 16616745 | MICROFLUIDIC CHIP FOR CIRCULATING TUMOR CELL SEPARATION, CIRCULATING TUMOR CELL SEPARATION METHOD AND COUNTING METHOD | November 2019 | December 2022 | Abandon | 37 | 1 | 1 | No | No |
| 16616665 | System and Method for Paper-Based Cryopreservation | November 2019 | April 2023 | Allow | 40 | 2 | 1 | No | No |
| 16616636 | A PROCESS TO PREPARE ELEMENTAL SULPHUR | November 2019 | January 2022 | Allow | 25 | 2 | 1 | No | No |
| 16614819 | MODIFIED TEMPLATE-INDEPENDENT DNA POLYMERASE | November 2019 | October 2024 | Allow | 59 | 5 | 1 | No | No |
| 16614195 | DEFOAMER FOR FERMENTER, AND MICROORGANISM FERMENTER USING DEFOAMER FOR FERMENTER | November 2019 | September 2022 | Allow | 34 | 1 | 1 | No | No |
| 16612756 | METHODS AND COMPOSITIONS OF INCORPORATING A BIOACTIVE AGENT AND USE THEREOF | November 2019 | December 2021 | Abandon | 26 | 3 | 1 | No | No |
| 16610625 | BLOOD VESSEL MIMIC AND METHOD FOR CULTURING BLOOD VESSEL MIMIC | November 2019 | January 2025 | Abandon | 60 | 5 | 1 | Yes | Yes |
| 16672056 | IDENTIFYING STATUS OF MALE FERTILITY BY DETERMINING SPERM CAPACITATION AND COMPANION COLLECTION KIT | November 2019 | March 2025 | Abandon | 60 | 4 | 1 | No | No |
| 16610325 | Polymeric Carriers and Methods | November 2019 | September 2022 | Allow | 35 | 1 | 1 | No | No |
| 16664264 | BIOCIDE COMPOSITIONS COMPATIBLE WITH ENZYME BIOSENSORS AND METHODS OF USE THEREOF | October 2019 | December 2023 | Allow | 49 | 4 | 1 | Yes | No |
| 16500071 | MEDIA FOR MICROORGANISM CULTURE AND RELATED COMPOSITIONS AND METHODS | October 2019 | March 2022 | Abandon | 29 | 0 | 1 | No | No |
| 16496523 | PERFUSION MEDIUM | September 2019 | October 2023 | Abandon | 49 | 3 | 1 | No | No |
| 16574984 | Methanothermobacter Thermautotrophicus Strain and Variants Thereof | September 2019 | March 2022 | Abandon | 30 | 1 | 1 | No | No |
| 16574587 | DEVICES AND METHODS FOR ISOLATING A MIGRATORY CELL POPULATION | September 2019 | December 2024 | Allow | 60 | 5 | 1 | Yes | No |
| 16494197 | METHODS AND COMPOSITIONS FOR MODULATION OF IMMUNE CELLS | September 2019 | March 2024 | Abandon | 54 | 4 | 1 | No | No |
| 16493996 | A METHOD OF INHIBITING ISOMERIZATION OF A REDUCING SACCHARIDE UPON THERMAL TREATMENT | September 2019 | March 2025 | Abandon | 60 | 7 | 1 | Yes | Yes |
| 16570626 | METHOD FOR SEPARATING MEGAKARYOCYTES AND PLATELETS AND INSTRUMENT FOR SEPARATING MEGAKARYOCYTES AND PLATELETS | September 2019 | December 2022 | Abandon | 39 | 2 | 0 | Yes | No |
| 16492715 | RAPID DETECTION OF E. COLI IN A THIN FILM CULTURE DEVICE | September 2019 | February 2022 | Allow | 29 | 1 | 0 | No | No |
| 16562529 | SOLID MEDIUM FOR PRODUCING GLUCOSAMINE AND ITS APPLICATION | September 2019 | April 2022 | Allow | 31 | 1 | 1 | No | No |
| 16560597 | COMPOSITIONS AND METHODS FOR IDENTIFYING METABOLICALLY ACTIVE AGENTS | September 2019 | October 2021 | Allow | 25 | 1 | 1 | No | No |
| 16489153 | TRYPSIN-LIKE SERINE PROTEASES AND USES THEREOF | August 2019 | May 2022 | Allow | 33 | 1 | 0 | Yes | No |
| 16550810 | MEDICINES FOR TOPIC USE BASED ON SULFATED HYALURONIC ACID AS ACTIVATING OR INHIBITING AGENT OF THE CYTOKINE ACTIVITY | August 2019 | August 2021 | Allow | 24 | 1 | 1 | Yes | No |
| 16549140 | System, Method, and Composition for Incubating Spores for Use in Aquaculture, Agriculture, Wastewater, and Environmental Remediation Applications | August 2019 | May 2022 | Allow | 32 | 1 | 1 | No | No |
| 16549757 | Bioreactor Paradigm for the Production of Secondary extra-Particle Hyphal Matrices | August 2019 | September 2021 | Allow | 25 | 0 | 0 | No | No |
| 16545097 | DETECTION OF NUCLEASE EDITED SEQUENCES IN AUTOMATED MODULES AND INSTRUMENTS | August 2019 | January 2024 | Allow | 53 | 2 | 1 | No | No |
| 16486600 | TRANSPARENT DISC-SHAPED MICROPARTICLES COATED WITH POLYDOPAMINE | August 2019 | July 2022 | Allow | 35 | 2 | 0 | Yes | No |
| 16542121 | LINKING METHODS, COMPOSITIONS, SYSTEMS, KITS AND APPARATUSES | August 2019 | July 2021 | Abandon | 23 | 1 | 0 | No | No |
| 16541938 | CELL CULTURE SUBSTRATE HAVING TWO ACRYLATE STRUCTURAL UNITS | August 2019 | October 2023 | Abandon | 50 | 4 | 0 | Yes | No |
| 16541848 | CELL CULTURE SUBSTRATE COMPRISING A COPOLYMER AND A STRUCTURAL UNIT | August 2019 | September 2023 | Abandon | 49 | 4 | 1 | No | No |
| 16541897 | CELL CULTURE SUBSTRATE HAVING A STRUCTURAL UNIT DERIVED FROM FURFURYL (METH) ACRYLATE | August 2019 | August 2023 | Allow | 48 | 4 | 0 | Yes | No |
| 16541989 | CELL CULTURE SUBSTRATE HAVING AN ACRYLATE STRUCTURAL UNIT AND A MONOMER STRUCTURAL UNIT | August 2019 | February 2023 | Allow | 42 | 2 | 0 | Yes | No |
| 16508228 | CELL CULTURE SUBSTRATE, CULTURE VESSEL, METHOD FOR PRODUCING CELL CULTURE VESSEL, METHOD FOR OBTAINING CELLS AND METHOD FOR CULTURING CELLS | July 2019 | February 2023 | Allow | 44 | 3 | 0 | Yes | No |
| 16453323 | MICROORGANISMS AND METHODS FOR THE PRODUCTION OF FATTY ACIDS AND FATTY ACID DERIVED PRODUCTS | June 2019 | November 2021 | Allow | 29 | 1 | 0 | No | No |
| 16446802 | Methods of Manufacturing and Assembling Cell-Containing Blocks | June 2019 | May 2022 | Allow | 35 | 1 | 1 | Yes | No |
| 16436578 | Biomaterial for Suturing | June 2019 | May 2021 | Allow | 24 | 1 | 0 | No | No |
| 16467535 | CELL CULTURE SUBSTRATE | June 2019 | January 2022 | Allow | 31 | 1 | 0 | Yes | No |
| 16428560 | COMPOSITIONS AND METHODS FOR DISRUPTING BIOFILM FORMATION AND MAINTENANCE | May 2019 | August 2022 | Allow | 38 | 2 | 2 | Yes | No |
| 16464084 | MICROORGANISM TEST SYSTEM | May 2019 | May 2022 | Abandon | 36 | 1 | 1 | No | No |
| 16461397 | MICROBIAL DETECTION DEVICES INCLUDING ADHESIVE MASKED NUTRIENTS AND METHODS OF USING THE SAME | May 2019 | June 2022 | Allow | 37 | 2 | 1 | Yes | No |
| 16411395 | PERIPHERAL DIAGNOSTIC METHODS FOR SCREENING ALZHEIMER'S DISEASE USING BETA AMYLOID AND INTERCELLULAR COMMUNICATION | May 2019 | May 2021 | Allow | 24 | 2 | 0 | No | No |
| 16349237 | PROTEASE SENSOR MOLECULES | May 2019 | November 2023 | Allow | 54 | 3 | 1 | Yes | No |
| 16407026 | SYSTEM AND METHOD FOR ORGANOID CULTURE | May 2019 | August 2022 | Allow | 39 | 3 | 1 | Yes | Yes |
| 16348170 | METHODS FOR CONVECTIVELY-DRIVEN INTRACELLULAR DELIVERY | May 2019 | September 2021 | Allow | 28 | 1 | 1 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BARRON, SEAN C.
With a 35.3% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 18.2% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner BARRON, SEAN C works in Art Unit 1653 and has examined 560 patent applications in our dataset. With an allowance rate of 51.2%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 38 months.
Examiner BARRON, SEAN C's allowance rate of 51.2% places them in the 15% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by BARRON, SEAN C receive 2.83 office actions before reaching final disposition. This places the examiner in the 79% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by BARRON, SEAN C is 38 months. This places the examiner in the 28% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +34.0% benefit to allowance rate for applications examined by BARRON, SEAN C. This interview benefit is in the 81% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 17.0% of applications are subsequently allowed. This success rate is in the 17% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 18.8% of cases where such amendments are filed. This entry rate is in the 24% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 54.5% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 48% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.
This examiner withdraws rejections or reopens prosecution in 63.0% of appeals filed. This is in the 42% percentile among all examiners. Of these withdrawals, 65.5% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 85.0% are granted (fully or in part). This grant rate is in the 86% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.5% of allowed cases (in the 60% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).
Quayle Actions: This examiner issues Ex Parte Quayle actions in 2.8% of allowed cases (in the 74% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.